通过综合PKPD模型评估sNfL作为Paclitaxel诱导的外周神经毒性生物标志物
Eman I K Ibrahim1, Milda Girdenyté1,2, Yang Hu1,3
1Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Pharmaceutical research
|March 14, 2026
概括
这项研究模拟了帕克利塔塞尔如何引起神经损伤,将药物暴露与血清神经丝光链 (sNfL) 水平联系起来. 该模型为了解帕克利塔塞尔诱导的外周神经毒性 (PIPN) 和指导临床研究提供了一个框架.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 神经科学是一个神经科学.
- 生物标志物研究 生物标志物研究
背景情况:
- 血清神经丝光链 (sNfL) 是帕克利塔塞尔诱导的外周神经毒性 (PIPN) 的有前途的生物标志物.
- 连接帕克利塔塞尔与外围组织NfL变化的精确机制尚不清楚.
- 临床前研究对于阐明这些机制联系至关重要.
研究的目的:
- 开发一个半机械的药理动力学-药理动力学 (PK-PD) 模型.
- 描述与PIPN相关的帕克利塔塞尔度和NfL动力学.
- 建立一个临床前框架,以了解帕克利塔塞尔的神经毒性.
主要方法:
- 使用动物数据开发了一种半机械PK-PD模型.
- 模拟的总和未结合的帕克利塔塞尔在血和PIPN位点.
- 描述了帕克利塔塞尔-图布林复合体的形成和NfL动力学.
主要成果:
- 该模型准确地捕捉了帕克利塔塞尔的药理动力学,包括血和组织分布.
- 帕克利塔塞尔-图布林结合动力学是容量有限的,并且随着重复剂量增加而增加.
- NfL动力学与帕克利塔塞尔-图布林复合体形成有关,尽管在验证中出现了一些低预测.
结论:
- 开发的模型成功地描述了帕克利塔塞尔暴露与sNfL动力学之间的关系.
- 这为PIPN的翻译研究提供了一个有价值的基于模型的框架.
- 可能需要进一步的研究,以充分解释在重复剂量下NfL动态.
相关概念视频
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
59
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
59
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
386
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
386